熱門資訊> 正文
NKTR, IMNM and MAIA are among premarket gainers
2024-04-30 20:42
- Gainers: Cyclacel Pharmaceuticals Inc (CYCC) +60% FORM 10-K/A | Amended Annual Report.
- Auddia Inc (AUUD) +34% Announces Strategic Product Expansion With Cloud Based Artificial Intelligence and Natural Language Processing Offering
- Marin Software Inc (MRIN) +32% Launches AI-powered Anomaly Detector to Unlock Growth in Performance Marketing Campaigns
- GeneDx Holdings Corp (WGS) +24% Q1 earnings call release
- BioRestorative Therapies Inc (BRTX) +21% Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
- LL Flooring Holdings Inc (LL) +17% receives all-cash buyout proposal.
- Blend Labs (BLND) +16% FORM DEF 14A | Proxy Statement (definitive).
- Mullen Automotive (MULN) +15%.
- Lantronix (LTRX) +14% Q3 earnings call release
- Addex Therapeutics (ADXN) +13% stock plunges 50% on failed study for epilepsy drug.
- Oatly Group (OTLY) +8% rallies after showing margin improvement in Q1.
- PayPal Holdings (PYPL) +8% stock climbs after Q1 earnings beat, with strong total payment volume.
- X4 Pharmaceuticals (XFOR) +7% FORM DEF 14A | Proxy Statement (definitive).
- Moolec Science (MLEC) +7% Announces New Patent Granting in the United States for Molecular Farming Platform.
- Lilly(Eli) (LLY) +7% raises guidance on weight loss momentum.
- 3M (MMM) +6% Q1 earnings call release
- BranchOut Food (BOF) +6%.
- Tenax Therapeutics (TENX) +6% Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
- NanoViricides (NNVC) +6% Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon.
- NKGen Biotech (NKGN) +6%.
- Immunome (IMNM) +5%.
- MAIA Biotechnology (MAIA) +6%.
- Nektar Therapeutics (NKTR) +5%.
More on premarket gainers & stock
- Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test
- Immunome: An Oncology Powerhouse In The Making
- Nektar Therapeutics (NKTR) Q4 2023 Earnings Call Transcript
- MAIA Biotechnology announces share purchase by director Stan Smith in private placement
- MAIA Biotechnology announces $1M private placement
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
